Paul Thomas

Mr. Paul G.
Thomas is an Independent Director at TELA Bio, Inc., a Chairman at Axogen, Inc. and a Chief Executive Officer & Director at Prominex, Inc. (California).
He is on the Board of Directors at TELA Bio, Inc., Prominex, Inc. (California), Surgalign Spine Technologies, Inc., Roka Bioscience, Inc. and Biotechnology Innovation Organization.
Mr. Thomas was previously employed as a Chief Executive Officer by Prominex, Inc., an Independent Director by Surgalign Holdings, Inc., an Independent Director by Aegerion Pharmaceuticals, Inc., an Independent Director by ABIOMED, Inc., a President, Chief Executive Officer & Director by Roka Bioscience, Inc., a Chairman, President & Chief Executive Officer by LifeCell Corp., a President & Director by Genzyme Corp., a President-Pharmaceutical Products Division by Ohmeda, Inc., a Trustee by Hambrecht & Quist Healthcare Investors, a Chairman by New England Healthcare Institute, and a President-Pharmaceutical Products by Ohmeda Medical, Inc. He also served on the board at Cohera Medical, Inc., Orthovita, Inc., Innovative Spinal Technologies, Inc. and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from St. Michael's College, a graduate degree from Graduate School of Georgia University and an MBA from Columbia Business School.